Liver Disease in Acute Medicine

Similar documents
Evaluation and Prognosis of Patients with Cirrhosis

End Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012

NUTRITION IN LIVER DISEASES

Patterns of abnormal LFTs and their differential diagnosis

June 11, 2015 Tim Halterman

COMPLICATIONS OF CIRRHOSIS: CASES. Anil Seetharam, MD

THE YELLOW PATIENT : Acutely Presenting Decompensated Chronic Liver Disease. Dr Shahid A Khan. Case. Q for Discussion:

a series of fact sheets written by experts in the field of liver disease HCV DISEASE PROGRESSION

COMPLICATIONS OF CIRRHOSIS COMPLICATIONS OF CIRRHOSIS OBSERVATIONS OF AN AGING HEPATOLOGIST. Philip C. Delich, M.D.

MANAGEMENT OF LIVER CIRRHOSIS

Perspective End-Stage Liver Disease in HIV Disease

Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012

A 55 year old man with cirrhosis due to chronic hepatitis C (CHC) genotype 3a is referred for liver transplantation.

A CASE OF LIVER CIRRHOSIS & HEPATIC ENCEPHALOPATHY

Liver Failure. Nora Aziz. Bones, Brains & Blood Vessels

PRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT

Complications of Cirrhosis

Approach to Abnormal Liver Tests

Alcoholic Hepatitis (Teacher s Guide)

Perspective Advanced Liver Disease: What Every Hepatitis C Virus Treater Should Know

Transmission of HCV in the United States (CDC estimate)

Liver Function Tests. Dr Stephen Butler Paediatric Advance Trainee TDHB

Precipitating Factors of Hepatic Encephalopathy

Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis

Management of Chronic Liver Disease. Dr Melissa Haines Gastroenterologist Waikato Hospital

Review: How to work up your patient with Hepatitis C

The following should be current within the past 6 months:

The most serious symptoms of this stage are:

23/06/2014. Nutrition in Chronic Liver Disease. Objectives. Question #1

Acute on Chronic Liver Failure: Current Concepts. Disclosures

CIRRHOSIS REFERRAL & MANAGEMENT GUIDELINES for the Southern Adelaide Local Health Network (SALHN)

Adams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS

Cirrhosis and Ascites. Thomas S. Foster, Pharm.D. Integrated Therapeutics PHR 961

1802 CLINICAL REVIEWS

Living With Hepatic Encephalopathy (HE)

LIVER TRANSPLANTATION IN ALAGILLE SYNDROME

Oral Zinc Supplementation as an Adjunct Therapy in the Management of Hepatic Encephalopathy: A Randomized Controlled Trial

Cirrhosis and HCV. Jonathan Israel M.D.

Hepatocellular Carcinoma (HCC)

HYPERTENSION ASSOCIATED WITH RENAL DISEASES

OMG my LFT s! How to Interpret and Use Them. OMG my LFT s! OMG my LFT s!

After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH

Liver, Gallbladder, Exocrine Pancreas KNH 406

Management of hepatitis C: pre- and post-liver transplantation. Piyawat Komolmit Bangkok

CARDIOVASCULAR DYSFUNCTION IN LIVER CIRRHOSIS

Screening for Varices and Prevention of Bleeding

NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation

Hepatitis C. Laboratory Tests and Hepatitis C

Investigation and treatment of liver disease with acute onset Local hospital protocol

Presents: Insider tips for the life insurance medical exam. Know what they are testing for--and how to get the best results.

CASE REPORT. T. L. Krishnamoorthy 1, M. Taneja 2 & P. E. Chang 1. Key Clinical Message

Complications of Chronic Liver Disease

PERITONEAL (ABDOMINAL) PARACENTESIS

Review Group: Mental Health Operational Medicines Management Group. Signature Signature Signature. Review Date: December 2014

REVIEW CLINICAL REVIEWS

Hepatic Encephalopathy, Hyperammonemia, and Current Treatment in ICU Room

Liver Diseases. An Essential Guide for Nurses and Health Care Professionals

Hypertension Guidelines

Fast Facts. Fast Facts: Liver Disorders. Thomas Mahl and John O Grady Health Press Ltd.

Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease. From : New England Journal of Medicine

Guideline for the Management of Nephrotic Syndrome

Albumin. Prothrombin time. Total protein

{ Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta Analysis}

Liver, Gallbladder and Pancreas diseases. Premed 2 Pathophysiology

Managing LFT s in General Practice

NHS FORTH VALLEY RIVAROXABAN AS TREATMENT FOR DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN ADULTS

AASLD PRACTICE GUIDELINES Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis

REFERENCE. Admit to: Program/Service: Diagnosis: Droplet/ Contact Airborne/ Contact

NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation

HCV/HIVCo-infection A case study by. Dominic Côté, Nurse Clinician B.Sc Chronic Viral Illness Services McGill University Health Centre

Rheumatoid Arthritis. GP workshop 15 January 2011

Hepatitis C Treatment Expansion Initiative Multi-Site Conference Call. March 16, 2011

Recanalized Umbilical Vein in the Presence of Cirrhosis-Induced Portal Hypertension

Approach to Abnormal Liver Tests

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Clinical Aspects of Hyponatremia & Hypernatremia

Department of Veterans Affairs VHA HANDBOOK Washington, DC March 1, 2005 COMMUNITY HOSPICE CARE: REFERRAL AND PURCHASE PROCEDURES

Visual Acuity. Hearing. Height and Weight. Blood Pressure MEASURED VALUE

P AC K AG E L E AF L E T: INFORMAT I ON FO R THE USER. 500 mg, film-coated tablet Active substance: metformin hydrochloride

Interpretation of Laboratory Values

Fatty Liver. Fatty liver caused from alcohol use can worsen into a more severe disease including alcoholic hepatitis and cirrhosis.

Clinical Case n. 3 Massimo Puoti AO Ospedale Niguarda Ca Granda Milano, Italy

Alcoholic hepatitis describes liver inflammation caused by drinking alcohol.

Lothian Diabetes Handbook MANAGEMENT OF DIABETIC KETOACIDOSIS

HEPATOLOGY CLERKSHIP

Lung Pathway Group Pemetrexed and Cisplatin in Non-Small Cell Lung Cancer (NSCLC)

Program Disclosure. This program is supported by an educational grant from Salix Pharmaceuticals.

Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs

You, Your Liver and Alpha-1. Skinny Little Reference Guide

DVT/PE Management with Rivaroxaban (Xarelto)

Subject: Severe Sepsis/Septic Shock Published Date: August 9, 2013 Scope: Hospital Wide Original Creation Date: August 9, 2013

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW

The new Heart Failure pathway

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below

ESIM 2014 WHEN CHRONIC BECOMES ACUTE

TOTAL PARENTERAL NUTRITION (TPN) Revised January 2013

Gastrointestinal bleeding: the management of acute upper gastrointestinal bleeding

GRASP-AF Coming to a PCT near you.

Hepatic Encephalopathy (Brain Disorder Secondary to Liver Disease) Basics

Living With Advanced Liver Disease

Transcription:

Liver Disease in Acute Medicine Jeffrey S Wong July 2012

Decompensated Liver Disease Hyponatraemia Variceal bleeding Ascites Management Hepatic Encephalopathy Toms Questions

Hyponatraemia in CLD Increasing severity of portal hypertension

Hyponatraemia in CLD A case 55 y.o man with known ALD Presents with increasing ascites Medications: Spironolactone 100mg OD, Frusemide 40mg OD Bloods Bili 25, Alb 30 Urea 6, Creatinine 65 Na + 128, K + 4.5

What do you do? 1. Discontinue Diuretics 2. Continue Diuretic and Fluid restrict to 1000mL/D 3. Continue Diuretic and further Salt restrict to 44 mmol/d 4. Continue Diuretic and commence saline to correct Na + 5. Increase Diuretic

What do you do? 1. Discontinue Diuretics 2. Continue Diuretic and Fluid restrict to 1000mL/D 3. Continue Diuretic and further Salt restrict to 44 mmol/d 4. Continue Diuretic and commence saline to correct Na + 5. Increase Diuretic

Diuretics in Hyponatraemia Serum sodium Action > 125 mmol/l No change 121-125 mmol/l No consensus Rate of fall of sodium Amount of Ascites Renal impairment < 121 mmol/l Stop diuretics Fluid Restrict

Hyponatraemia associated with More severe liver disease More frequent SBP Diuretic resistance More frequent HRS Higher mortality

Variceal bleeding

A case 48 yo man HCV and ALD P/C Haematemesis Pulse 120, BP 110/65 L and 85/55 S Bloods Hb 90, Platelets 75, INR 1.5 Creatinine 100, Urea 25 Bilirubin 55, ALT 30, AST 50, GGTP 345, ALP 100

What should be included in the plan? Commence antibiotics Assessment of CPT/MELD score Discussion with Gastroenterology/Hepatology Commence vasoactive drug (Octreotide/Terlipressin) Transfuse to target Hb 100

What should be included in the plan?

Antibiotics in acute variceal bleeding Acute variceal bleeding in cirrhotics Mortality of 20% Infection rate of 25-50% Cochrane review 2009 Mortality RR reduction 29% (6-46) Infection RR reduction 58% (48-66) Chavez-Tapia Norberto C, Soares-Weiser Karla, Brezis Mayer, Leibovici Leonard. Antibiotics for spontaneous bacterial peritonitis in cirrhotic patients. Cochrane Database of Systematic Reviews: Reviews 2009 Issue 1

Other Mortality in variceal bleeding best predicted by stage of liver disease using whatever scoring system you are familiar with (CPT/MELD etc..) Vasoactive drugs should be instituted when variceal bleeding is suspected i.e prior to endoscopy and in the case of Terlipressin has been shown to reduce mortality Endoscopy should be performed as soon as possible Diagnosis Control bleeding Risk stratify

Ascites Management: A case 65 yo man Background ALD and DCM (EtoH) Ascites Salt restriction Multiple previous LVP Frusemide 500mg Spironolactone 160mg CPT score: A Represents with ascites Findings Pulse 88, BP 105/65 Raised JVP++ Tense ascites Bloods Na + 130, K + 5.2 Creatinine 133

What should you do next? Consider peritoneovenous shunt Consider TIPS (Trans jugular porto-systemic shunt) Urinary Na + to assess diuretic effect/compliance Give up and continue LVP with Albumin Carefully increase Spironolactone

What should you do next?

Notes Peritoneovenous shunts abandoned TIPS contraindicated in heart failure Difficult to assess urinary Na + If high need to be certain of dietary intake If low can indicate poor response or poor compliance Repeated LVP still valid option for many patients Usual Spiro/Frusemide ratio is 100/40 but strategy when coexistent heart failure is not known

Hepatic Encephalopathy Hepatic encephalopathy (also known as portosystemic encephalopathy) is the occurrence of confusion, altered level of consciousness, and coma as a result of liver failure Treatments Lactulose Non absorbed antibiotics LOLA (L-ornithine L-aspartate)

A case 75 yo woman with cirrhosis secondary to AIH Stable disease Azathioprine with normal ALT Maintenance EVL Emergency laparotomy for SBO without decompensation Presented with AMI Day 3 found comatose No alternative cause found No response to Lactulose Decision to palliate

Case continued She then woke up!

Tips for care of patients with HE Don t give up Lactulose Use lots of it Use large amount frequently Use rectally if required Do not use low protein diets HE indicates a poor prognosis 1 y survival 42% and 3 y survival 23%

Toms Questions Spontaneous Bacterial Peritonitis diagnosis Value of Vitamin K as it never seems to work Terlipressin: When should this be used? TIPS: What is it and what are the indications? Steroids in Alcoholic Hepatitis How much alcohol is required for ALD?

Spontaneous bacterial peritonitis Spontaneous Bacterial Peritonitis Culture negative neutrocytic Ascites Mono-microbial nonneutrocytic Bacterascites Neutrophils Culture Other >250 cells/mm 3 Positive >250 cells/mm 3 Negative Indistinguishable from above <250 cells/mm 3 Positive If symptomatic should be treated as above Secondary Bacterial Peritonitis >250 cells/mm 3 Positive (multiple) High LDH Low Glucose

Vitamin K In CLD Reduction in both pro and anti-coagulant factors INR only assesses vitamin K dependent pathways At least 25% of CLD patients are Vitamin K deficient Especially in malnourished, EtoH, and Cholestatic CLD Standard tests of coagulation are not predictive of bleeding in patients with Liver Disease Replenishment 10mg i.v OD for three days and then 10mg i.v once per week maintenance

Terlipressin Vasopressin (ADH) analogue Most important effects V1a (vasoconstriction) V2 (solute free water reabsorption) Indications Variceal bleeding HRS

TIPS (transjugular intrahepatic portosystemic shunt) Radiological placement of a porto systemic stent Reduces portal pressure and it s sequelae Indications Refractory variceal bleeding Refractory ascites

Steroids in Alcoholic Hepatitis Should it be used? Maddrey Score Bilirubin Prothrombin time Control Prednisone for score >32 may reduce mortality but Many contraindications Concern re sepsis Higher mortality if score >52 Is it working? Lille score Age day 0 Albumin day 0 Bilirubin day 0 and 7 Creatinine day 0 INR day 0 Survival at 6 months >45 25% <45 85%

How much alcohol is too much? How much do you drink Tom?

Final words Decompensated CLD patients Are often very complex Are often very unwell if they look fine Are often fine even if they look unwell Have a highly fluctuant course Your mobile device is your friend Scores can be difficult to memorise Should be referred early